News | Neurological conditions

Opinion

Lessons from testing 2,300 patients at the UK’s first CYP2C19 genotyping system 

Specialist clinical pharmacist Alex Matos explains what his team has learned in the two years since setting up the NHS Tayside project to genotype acute stroke patients with an indication for clopidogrel.…

Published: 19 August 2024

Feature

Changes in migraine treatment: how new classes of drugs can provide additional options for patients and prescribers

This episode of The PJ Pod looks at recent changes to National Institute for Health and Care Excellence guidance on the treatment of acute and chronic migraine and what pharmacists should expect from the new class of gepant drugs.…

Published: 2 August 2024

News

NICE recommends tenecteplase for treating acute ischaemic stroke patients

Tenecteplase was found to be as effective as alteplase, which is more expensive, and the National Institute for Health and Care Excellence said its decision could save the NHS “millions”.…

Published: 26 July 2024

News

Combination treatment significantly increases chance of five-year Alzheimer’s survival, study results show

Experts said the large study had found "small but significant effects" of combination treatment with donepezil and memantine in Alzheimer's disease.…

Published: 17 June 2024

News

ADHD hub planned for launch in autumn 2024

The hub will support shared-care arrangement for adults with attention deficit hyperactivity disorder in Leeds, West Yorkshire.…

Published: 17 May 2024

News

ADHD drugs back in stock, says manufacturer 

Exclusive: Medicines used to treat ADHD manufactured by Takeda are now available, following a period of supply issues caused by an increase in demand and production challenges.…

Published: 16 May 2024

News

Antipsychotic drugs in dementia treatment associated with range of adverse reactions

Experts say the findings suggest that the risks of prescribing antipsychotics in people with dementia “may be more severe than previously understood”.…

Published: 24 April 2024

News

More than 40% of people with ADHD waiting at least two years to access mental health service, study finds

Healthcare professionals, integrated care board commissioners and people with lived experience of ADHD all reported extended wait times for adult mental health services.…

Published: 19 April 2024

News

Erectile dysfunction drugs may reduce Alzheimer’s risk, study suggests

Results from a study of more than 260,000 men has suggested those taking erectile dysfunction drugs were 18% less likely to develop Alzheimer's disease than those not taking the drugs.…

Published: 8 February 2024

News

Medicines regulator seeks expert advice on risk of developmental disorders in children fathered by men on valproate

The Medicines and Healthcare products Regulatory Agency is to look again at evidence from a study evaluating the link between paternal valproate exposure and developmental disorders in children.…

Published: 16 January 2024